ibusinesslines.com
ibusinesslines.com May 27, 2018


Trian Fund Management seeks to seat Nelson Peltz on P&G board

17 July 2017, 09:40 | Kelvin Horton

Trian Fund Management seeks to seat Nelson Peltz on P&G board

CNBC Events- Season 2014

Trian said it was disappointed by the rejection and advised those in attendance it would push ahead with a proxy fight.

The Trian Fund Management investment firm on Monday said it nominated Nelson Peltz for a board seat at Procter & Gamble to shake up the stalled consumer-products giant.

Calling P&G's financial results over the last decade "disappointing", Trian cited weak shareholder returns, deteriorating market share and excessive cost and bureaucracy in the Securities and Exchange Commission filing that announced the challenge. We believe P&G needs to address the factors contributing to this consistent underperformance. "Trian believes P&G must take decisive action that goes above and beyond what P&G has presently committed to do".

The firm, which initially revealed its position in February, now holds 37.6 million P&G shares, or about 1.5 percent.

However, it does want to bring change to the company, which includes cutting cost and management. "The board is confident that the changes being made are producing results, and expresses complete support for the company's strategy, plans, and management". Meanwhile, the company is losing market share in various categories yet it's the only company in the world that boasts over 20 billion-dollar brands.


In a CNBC interview on Monday, Peltz said he spoke with former Gillette employees who said they wouldn't have let online rivals Dollar Shave Club and Harry's gain as much of a foothold as P&G did.

But that has hurt sales, which have declined over the past three years, and the company's share price. Nor was it seeking to replace the company's chief executive of less than two years, David S. Taylor.

Shares of P&G are up less than 4 percent this year.

Trian and Procter & Gamble Co were close to reaching an agreement that would allow Peltz to join the Board if public goals weren't met, but the discussions fell apart in May. Dan Loeb's Third Point disclosed last month that it had amassed a $3.5 billion stake in Nestle, encouraging the company to sell its stake in cosmetics maker L'Oreal and increase leverage for share buybacks.



Other News

Trending Now

Micromax launches 'Canvas 1' at Rs 6999
It comes with slim bezels on the edges and front comes with the selfie camera module, the earpiece grille, and the display. A few weeks earlier we have seen, the company launching Canvas 2 (2017 ) which is the successor of last years Canvas 2 .

Pacer Advisors Inc. Has $1.26 Million Position in NextEra Energy, Inc. (NEE)
The utilities provider reported $1.75 earnings per share for the quarter, beating analysts' consensus estimates of $1.51 by $0.24. Three investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the company's stock.

Trump's approval rating dips to 36%
Trump's approval rating has risen 10 percent since the same poll was conducted last month-from 40 to 50 percent, NBC reported . But his return brings him straight back into the intensifying storm over his campaign's contacts with Russian Federation .

Wimbledon doubles joy for Kubot and Melo as final goes the distance
The partnership of the Polish and the Brazilian has achieved the pair the title of the Wimbledon Men's Double winners. The match being played at the Centre Court was suspended at 11-11 and then resumed with the roof being closed.

Cargo ship hits Green Bay bridge, crushes small boat
Barker, which has a gross tonnage of 25,900, had already delivered its cargo of coal. -With files from The Associated Press. The state Department of Transportation confirmed the draw bridge was hit and vehicle traffic was suspended and rerouted.

(NYSE:JPM), Tesla Inc (NASDAQ:TSLA)
Northwest Quadrant Wealth Management LLC acquired a new stake in J P Morgan Chase & Co during the fourth quarter worth $125,000. Equities research analysts anticipate that J P Morgan Chase & Co will post $6.62 earnings per share for the current year.

Alder BioPharmaceuticals, Inc. (ALDR) Set to Announce Quarterly Earnings on Monday
On average, equities research analysts expect that Eiger BioPharmaceuticals will post ($5.39) EPS for the current fiscal year. Over the last three months, the shares of the company have changed 8.82% and performed -21.28% over the last six months.